QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2022     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H 期刊论文 INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61 作者:  Guo, Huihui;  Zhang, Xilin;  Xie, Shangzhi;  Chen, Tianwei;  Xie, Dong 收藏  |  浏览/下载：17/0  |  提交时间：2022/12/22 gefitinib  CD28H  NSCLC  EGFR mutation   Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract 期刊论文 CANCER COMMUNICATIONS, 2022 作者:  Wu, Huanwen;  Yu, Zicheng;  Liu, Yueping;  Guo, Lei;  Teng, Lianghong 收藏  |  浏览/下载：22/0  |  提交时间：2022/12/22 Neuroendocrine carcinomas  Gastrointestinal tract  Genomic characterization  Heterogeneity  Therapeutic implications   Comprehensive evaluation of computational methods for predicting cancer driver genes 期刊论文 BRIEFINGS IN BIOINFORMATICS, 2022, 卷号: 23 作者:  Shi, Xiaohui;  Teng, Huajing;  Shi, Leisheng;  Bi, Wenjian;  Wei, Wenqing 收藏  |  浏览/下载：7/0  |  提交时间：2022/12/23 TCGA  computational method  cancer driver gene  performance evaluation  Pan-cancer analysis   Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2 期刊论文 LEUKEMIA, 2022 作者:  Yang, Jing;  Weisberg, Ellen L.;  Qi, Shuang;  Ni, Wei;  Mei, Husheng 收藏  |  浏览/下载：76/0  |  提交时间：2022/02/14 Repressing MYC by targeting BET synergizes with selective inhibition of PI3K alpha against B cell lymphoma 期刊论文 CANCER LETTERS, 2022, 卷号: 524, 页码: 206-218 作者:  Chen, Zi-qi;  Cao, Zhe-rui;  Wang, Yi;  Zhang, Xi;  Xu, Lan 收藏  |  浏览/下载：53/0  |  提交时间：2021/12/16 CYH33  MYC  P300  BET  B cell lymphoma  PI3K